This page lists the hematology hospitals in our directory offering Leukemia Treatment in Mumbai, India, including Nanavati Super Specialty Hospital, Kokilaben Dhirubhai Ambani Hospital, Tata Memorial Hospital, Apollo Hospitals, Navi Mumbai and others. Each listing links through to the hospital's full profile page.
Ask us about leukemia treatment in Mumbai, India
Share a few details and our care coordination team will get back to you with next steps.
Top Hospitals for Leukemia Treatment in Mumbai, India
🇮🇳 Nanavati Super Specialty Hospital
Patients considering leukemia treatment can be cared for by Nanavati Super Specialty Hospital's care team in Mumbai, India, from initial consultation through recovery. Nanavati Super Specialty Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 Kokilaben Dhirubhai Ambani Hospital
Patients considering leukemia treatment can be cared for by Kokilaben Dhirubhai Ambani Hospital's care team in Mumbai, India, from initial consultation through recovery. Kokilaben Dhirubhai Ambani Hospital, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 Tata Memorial Hospital
Patients considering leukemia treatment can be cared for by Tata Memorial Hospital's care team in Mumbai, India, from initial consultation through recovery. Tata Memorial Hospital, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 Apollo Hospitals, Navi Mumbai
Patients considering leukemia treatment can be cared for by Apollo Hospitals, Navi Mumbai's care team in Mumbai, India, from initial consultation through recovery. Apollo Hospitals, Navi Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 Gleneagles Hospital, Mumbai
Patients considering leukemia treatment can be cared for by Gleneagles Hospital, Mumbai's care team in Mumbai, India, from initial consultation through recovery. Gleneagles Hospital, Mumbai, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 Lilavati Hospital And Research Centre
Patients considering leukemia treatment can be cared for by Lilavati Hospital And Research Centre's care team in Mumbai, India, from initial consultation through recovery. Lilavati Hospital And Research Centre, accredited by JCI, NABH, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 Jaslok Hospital
Patients considering leukemia treatment can be cared for by Jaslok Hospital's care team in Mumbai, India, from initial consultation through recovery. Jaslok Hospital, accredited by NABH, NABL, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 Gleneagles Global Hospitals (Global Hospitals)
Patients considering leukemia treatment can be cared for by Gleneagles Global Hospitals (Global Hospitals)'s care team in Parel, Mumbai, India, from initial consultation through recovery. Gleneagles Global Hospitals (Global Hospitals), accredited by NABH, JCI, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 Medicover Hospital, Navi Mumbai
Patients considering leukemia treatment can be cared for by Medicover Hospital, Navi Mumbai's care team in Navi Mumbai, India, from initial consultation through recovery. Medicover Hospital, Navi Mumbai, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
🇮🇳 KIMS Hospitals, Thane
Patients considering leukemia treatment can be cared for by KIMS Hospitals, Thane's care team in Mumbai, India, from initial consultation through recovery. KIMS Hospitals, Thane, accredited by NABH, follows recognised patient-safety and quality-of-care standards when performing leukemia treatment.
Top Hematology Doctors in Mumbai, India
FeaturedDr. Muralidaran C
- 9+ years of experience in Hematologist & BMT Specialist
- Consultant Hematologist & Bone Marrow Transplant Physician, Wockhardt Hospital, Mumbai — Present
- Superspecialty Medical Officer, MCGM–CTC PHO BMT Centre, Mumbai
- Bone Marrow Aspiration and Biopsy
- Autologous Stem Cell Transplantation (ASCT)
- Allogeneic Bone Marrow Transplantation
- Haploidentical BMT with Haploidentical Donors
- Lymph Node Fine Needle Aspiration Cytology (FNAC)
Dr. Vipin Khandelwal
- 12+ years of experience in Paediatric Haematologist & BMT Specialist
- Consultant — Paediatric Haematology, Oncology & Bone Marrow Transplantation, Apollo Hospitals, Navi Mumbai
- Advanced training in Paediatric Haematology and Bone Marrow Transplantation
- Paediatric Bone Marrow Transplantation (BMT)
- Haploidentical Stem Cell Transplantation
- Matched Sibling Donor Transplant
- Matched Unrelated Donor Transplant
- Autologous Stem Cell Transplantation
How we selected these hospitals
A hospital appears on this page when Hematology is among its listed specialties and it is located in Mumbai, India. Hospitals are not ranked by a proprietary "best" score — the order follows the listed rating (highest first), the same field shown on each hospital's profile.
How to Select the Best Hospital for Leukemia Treatment in Mumbai, India?
Choosing the right hospital for leukemia treatment is one of the most important decisions in your treatment journey. A few factors are worth weighing before you decide:
International Accreditation
Look for a hospital with international accreditation such as JCI or NABH — see the accreditation badges shown for each hospital below.
Specialization
Check that the hospital's listed specialties actually include hematology rather than only general care.
Capacity and Track Record
Bed count and year established (shown below for each hospital) are a reasonable proxy for scale and operating experience.
Transparent Costs
Ask for an itemised, all-inclusive estimate — hospital charges, room category and stay — before you travel. Our cost calculator (linked below) gives a starting estimate.
Understanding Leukemia Treatment
Leukaemia treatment in India and the UAE encompasses a full spectrum of evidence-based oncology protocols — including induction and consolidation chemotherapy, precision-targeted molecular therapies (TKIs, BCL-2 inhibitors), and allogeneic or autologous Bone Marrow Transplantation (BMT) — delivering complete remission rates of 70–90% for ALL and 60–80% for AML in adult patients at leading centres.
Clinical Overview
- Leukaemia is a malignancy of haematopoietic stem cells characterised by the clonal proliferation of immature or dysfunctional white blood cells within the bone marrow, peripheral blood, and lymphoid tissues.
- The four principal subtypes — Acute Lymphoblastic Leukaemia (ALL), Acute Myeloid Leukaemia (AML), Chronic Lymphocytic Leukaemia (CLL), and Chronic Myeloid Leukaemia (CML) — differ substantially in their cytogenetic drivers, clinical behaviour, and therapeutic targets.
- In ALL, chromosomal translocations such as the Philadelphia chromosome (BCR-ABL1 fusion, present in 25–30% of adult ALL) or MLL rearrangements dictate both prognosis and treatment selection.
Who is a Candidate?
- ELIGIBILITY — GENERAL: Adults and paediatric patients with a confirmed haematological malignancy diagnosis (bone marrow biopsy, flow cytometry, cytogenetics, and molecular profiling are mandatory prerequisites before any treatment consultation)
- ACUTE LEUKAEMIA (ALL/AML): Newly diagnosed patients with ECOG performance status 0–2; patients with relapsed/refractory disease being evaluated for salvage therapy or transplant; patients who have failed 1–2 lines of prior therapy elsewhere seeking second-opinion protocol optimisation
- CML: Patients in chronic phase intolerant or resistant to first- or second-generation TKIs; patients in accelerated or blast phase being considered for third-generation TKI (ponatinib, asciminib) bridging to allo-HSCT
- CLL: Patients with del(17p) or TP53 mutation requiring BTK inhibitor (ibrutinib, acalabrutinib) or venetoclax-based therapy; Richter transformation requiring aggressive chemoimmunotherapy evaluation
- +20 more
Treatment Options & Approaches
- CHEMOTHERAPY PROTOCOLS Induction chemotherapy is the backbone of acute leukaemia management.
- For AML, the '7+3' regimen (cytarabine 100–200 mg/m² continuous infusion × 7 days + daunorubicin or idarubicin × 3 days) remains the standard induction platform, with CPX-351 (liposomal cytarabine/daunorubicin) now preferred for therapy-related AML or AML with myelodysplasia-related changes.
- For ALL, risk-stratified regimens such as hyper-CVAD (cyclophosphamide, vincristine, doxorubicin, dexamethasone alternating with methotrexate and cytarabine) or BFM-based protocols are employed.
Recovery
- PHASE 1 — PRE-ARRIVAL PREPARATION (2–4 WEEKS BEFORE TRAVEL) Step 1: GAF Healthcare receives all available medical records (bone marrow biopsy pathology, cytogenetics/NGS report, imaging, prior treatment history).
- A senior haematologist/oncologist at the partner centre reviews the case and issues a detailed second-opinion report with recommended treatment protocol, estimated duration, and cost estimate within 48–72 hours.
- Step 2: Patient and family complete the visa application.
Risks to be aware of
- Leukaemia treatment, particularly intensive chemotherapy and allogeneic BMT, carries significant and well-characterised risks that patients and families must understand before committing to therapy.
- During induction chemotherapy, the principal risks include febrile neutropaenia (occurs in >80% of AML induction patients), requiring prompt broad-spectrum IV antibiotics and antifungal escalation; tumour lysis syndrome (TLS), potentially causing acute renal failure, hyperkalaemia, and cardiac arrhythmias — mitigated by hyperhydration, allopurinol/rasburicase, and vigilant electrolyte monitoring; cardiotoxicity from anthracyclines (doxorubicin, idarubicin, daunorubicin), particularly cumulative cardiomyopathy with LVEF decline — monitored by serial echocardiography; and mucositis, hepatotoxicity, and neurotoxicity (vincristine-related peripheral neuropathy, high-dose methotrexate-related leukoencephalopathy).
Why GAF Healthcare
- GAF Healthcare provides a fully integrated, non-medical support infrastructure designed to eliminate logistical barriers for international patients and their families throughout the entire treatment journey.
Common questions about Leukemia Treatment
What is the cost of Leukaemia Treatment in India – Chemotherapy, Targeted Therapy & BMT in India vs UAE?
How long do I need to stay in the country before I am fit to fly home after Leukaemia Treatment?
What is the success rate of Leukaemia Treatment with Chemotherapy, Targeted Therapy, and BMT?
Related pages
How GAF Healthcare Assists in Choosing the Best Hospital for Leukemia Treatment in Mumbai, India
Discover the Top Hospitals for Leukemia Treatment in Mumbai, India
This page lists 17 accredited hematology hospitals in Mumbai, India, so you can compare accreditation, specialties and bed capacity in one place.
Support When You Need It Most
Share your medical reports with us on WhatsApp or email. Our medical team reviews them and comes back with a recommended hospital and treatment plan for your case.
Transparent, All-Inclusive Costs
We provide a single, itemised quote covering hospital charges and stay — no hidden fees, and there's no charge for requesting an estimate. Use our cost calculator alongside this page for a first estimate.
Visa, Travel and Stay Coordination
Once you choose a hospital, we help arrange the medical visa invitation letter, hotel or serviced-apartment booking nearby, airport pickup and transport to your appointments.
Curious what treatment might cost for your case? Use our cost calculator for a personalized estimate.
Patient Success Story
Frequently asked questions about leukemia treatment in Mumbai, India
How many hematology hospitals are listed in Mumbai, India?
How do you choose which hospitals to list?
How much does treatment cost in India?
Are there hematology hospitals for this in other India cities?
Are these hospitals internationally accredited?
Can I get a treatment plan and cost estimate before I travel?
Do you help with visa, travel and accommodation?
What support do I get during and after treatment?
What does the "Featured" label next to a hospital's name mean?
How do I get matched with the right hospital for leukemia treatment?
Does the listed cost cover everything?
Next Step
Share your medical reports with us and our team will recommend a hospital and treatment plan for leukemia treatment in Mumbai, India.
Contact us to report an inaccuracy on this page.